{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:56:48Z","timestamp":1787320608417,"version":"build-2736575974"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Lupus nephritis (LN) represents the most severe renal manifestation of systemic lupus erythematosus (SLE), and timely, risk-stratified intervention is essential to mitigate irreversible kidney damage and improve long-term clinical outcomes. The autoantibody repertoire not only constitutes a cornerstone of SLE diagnosis but also serves as a critical pathogenic link between systemic immune dysregulation and site-specific renal injury. This review synthesizes current evidence on established and emerging autoantibodies associated with LN, with an emphasis on their pathogenic contributions to three central mechanisms: immune complex deposition, complement system activation, and direct podocyte injury. We critically evaluate the clinical validity and utility of conventional serological markers, including anti-dsDNA and anti-C1q antibodies, for diagnosing LN, monitoring disease activity, and predicting renal flares or progression, while also elucidating the significance of distinct clinical phenotypes such as the antiphospholipid antibody profile. Furthermore, we discuss strategies for integrating multiple autoantibody indices to construct predictive models, as well as the application prospects of novel technologies enabling non-invasive liquid biopsy. Finally, the challenges and future directions of autoantibody-guided individualized therapy are discussed, with the goal of advancing precision clinical decision-making for LN.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1870304","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:57:41Z","timestamp":1783490261000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Autoantibody repertoire in lupus nephritis: from pathogenic mechanisms to clinical integration for precision decision-making"],"prefix":"10.3389","volume":"17","author":[{"given":"Ran","family":"Guo","sequence":"first","affiliation":[{"name":"Luoyang key laboratory of transplantation and immunological studies for haematological diseases, Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xue","sequence":"additional","affiliation":[{"name":"Luoyang key laboratory of transplantation and immunological studies for haematological diseases, Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyuan","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[{"name":"Luoyang key laboratory of transplantation and immunological studies for haematological diseases, Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liang","sequence":"additional","affiliation":[{"name":"Luoyang key laboratory of transplantation and immunological studies for haematological diseases, Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baotong","family":"Yang","sequence":"additional","affiliation":[{"name":"Luoyang key laboratory of transplantation and immunological studies for haematological diseases, Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetao","family":"Chen","sequence":"additional","affiliation":[{"name":"Luoyang key laboratory of transplantation and immunological studies for haematological diseases, Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Luoyang key laboratory of transplantation and immunological studies for haematological diseases, Department of Clinical Laboratory, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology","place":["Luoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences; Key Laboratory of Rheumatology & Clinical Immunology, Ministry of Education","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223880","article-title":"Annals of the Rheumatic Diseases collection on lupus nephritis (2019-2022): novel insights and advances in therapy","volume":"82","author":"Kostopoulou","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.10.017","article-title":"Update on lupus nephritis: Core curriculum 2020","volume":"76","author":"Parikh","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2008.12.018","article-title":"Clinical approach to lupus nephritis: recent advances","volume":"20","author":"Molino","year":"2009","journal-title":"Eur J Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-021-01010-4","article-title":"Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus","volume":"34","author":"Alkhatib","year":"2021","journal-title":"J Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.57751","article-title":"Silent storm unveiled: Lupus nephritis and cerebral vasculitis in systemic lupus erythematosus","volume":"16","author":"Sawant","year":"2024","journal-title":"Cureus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103404","article-title":"From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies","volume":"22","author":"Xipell","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103535","article-title":"A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence","volume":"23","author":"Bruschi","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac143","article-title":"Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis","volume":"33","author":"Asanuma","year":"2023","journal-title":"Mod Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2025.110487","article-title":"Anti-C1s autoantibodies as complementary serologic biomarker in lupus nephritis","volume":"275","author":"Vigne","year":"2025","journal-title":"Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000530928","article-title":"The role of anti-mCRP autoantibodies in lupus nephritis","volume":"9","author":"Yuan","year":"2023","journal-title":"Kidney Dis (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2024.05.019","article-title":"Anti-factor H autoantibodies in patients with lupus nephritis","volume":"163","author":"Mihaylova","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s363722","article-title":"Lupus nephritis: Current perspectives and moving forward","volume":"15","author":"Lichtnekert","year":"2022","journal-title":"J Inflammation Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/mnh.0000000000000792","article-title":"A review of the AURORA and BLISS trials: will it revolutionize the treatment of lupus nephritis","volume":"31","author":"Asif","year":"2022","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2024.2425387","article-title":"Real-world data in lupus nephritis: results from a European survey on renal function testing and burden of disease progression","volume":"40","author":"Pesce","year":"2024","journal-title":"Curr Med Res Opin"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/art.42766","article-title":"Local ancestry at the major histocompatibility complex region is not a major contributor to disease heterogeneity in a multiethnic lupus cohort","volume":"76","author":"Solomon","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.09.007","article-title":"Low-level proteinuria in systemic lupus erythematosus","volume":"5","author":"Chedid","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-06909-4","article-title":"Evaluation of type 2 SLE symptoms in patients with a range of lupus nephritis activity","volume":"43","author":"Rogers","year":"2024","journal-title":"Clin Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01715-1","article-title":"Lupus nephritis: Improving treatment options","volume":"82","author":"Kostopoulou","year":"2022","journal-title":"Drugs"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2021-001887","article-title":"Clinical and serological associations of autoantibodies in patients with systemic lupus erythematosus","volume":"69","author":"Correa-Rodr\u00edguez","year":"2021","journal-title":"J Investig Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/2374289520909496","article-title":"Educational case: Lupus nephritis as an example of immune complex-mediated glomerulonephritis","volume":"7","author":"Jebakumar","year":"2020","journal-title":"Acad Pathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/09612033211062535","article-title":"Extraglomerular immune complex deposition in lupus nephritis","volume":"31","author":"Papa","year":"2022","journal-title":"Lupus"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86406","article-title":"A rare case of seronegative lupus nephritis presenting as immune complex diffuse glomerulonephritis","volume":"17","author":"Yeboah","year":"2025","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210066","article-title":"Decipher the immunopathological mechanisms and set up potential therapeutic strategies for patients with lupus nephritis","volume":"24","author":"Tsai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s527859","article-title":"Anti-PS IgG immune complexes impair macrophage phagocytosis in SLE via LOX-dependent oxidative stress","volume":"18","author":"Guan","year":"2025","journal-title":"J Inflammation Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040626","article-title":"Expanding the role of complement therapies: The case for lupus nephritis","volume":"10","author":"Li","year":"2021","journal-title":"J Clin Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1624850","article-title":"Breaking the cycle: immune complexes, complement activation, and novel immunotherapies in lupus nephritis","volume":"16","author":"Dong","year":"2025","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2023.13091","article-title":"Immune podocytes in the immune microenvironment of lupus nephritis (Review)","volume":"28","author":"Liu","year":"2023","journal-title":"Mol Med Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/bor.0000000000000777","article-title":"Cellular aspects of the pathogenesis of lupus nephritis","volume":"33","author":"Chang","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2015.08.006","article-title":"The complement system in lupus nephritis","volume":"35","author":"Birmingham","year":"2015","journal-title":"Semin Nephrol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22820","article-title":"Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus","volume":"114","author":"Holers","year":"2004","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.trsl.2022.03.005","article-title":"Intertwined pathways of complement activation command the pathogenesis of lupus nephritis","volume":"245","author":"Satyam","year":"2022","journal-title":"Transl Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002517","article-title":"Dissecting signalling pathways associated with intrarenal synthesis of complement components in lupus nephritis","volume":"8","author":"Tampe","year":"2022","journal-title":"RMD Open"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-024-02603-6","article-title":"Lupus nephritis and related renal disease: review from case series","volume":"29","author":"Ubara","year":"2025","journal-title":"Clin Exp Nephrol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2025.102655","article-title":"Complement in systemic lupus erythematosus across time and space: from tolerance to tissue injury and from extracellular to intracellular functions","volume":"97","author":"Clavarino","year":"2025","journal-title":"Curr Opin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000831","article-title":"Molecular signatures of intrarenal complement receptors C3AR1 and C5AR1 correlate with renal outcome in human lupus nephritis","volume":"9","author":"Tampe","year":"2022","journal-title":"Lupus Sci Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/c58c39","article-title":"Predictors of renal flares and long-term renal outcome in patients with lupus nephritis: results from daily clinical practice","volume":"40","author":"Ligtenberg","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2020.112866","article-title":"Complement activation in human autoimmune diseases and mouse models; employing a sandwich immunoassay specific for C3dg","volume":"486","author":"Troldborg","year":"2020","journal-title":"J Immunol Methods"},{"key":"B40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11926-021-00984-1","article-title":"A review of complement activation in SLE","volume":"23","author":"Weinstein","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1177\/09612033231226351","article-title":"Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis","volume":"33","author":"Qin","year":"2024","journal-title":"Lupus"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1016-9_13","article-title":"Detection of anti-C3b autoantibodies by ELISA","volume":"2227","author":"Radanova","year":"2021","journal-title":"Methods Mol Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05499-1","article-title":"Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis","volume":"40","author":"Mejia-Vilet","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000240356.45550.13","article-title":"Pathogenesis and treatment of systemic lupus erythematosus nephritis","volume":"18","author":"Davidson","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000000000000887","article-title":"Pathogenesis of lupus nephritis: the contribution of immune and kidney resident cells","volume":"35","author":"Bhargava","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656090","article-title":"A novel autoantibody induced by bacterial biofilm conserved components aggravates lupus nephritis","volume":"12","author":"Fu","year":"2021","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000042858","article-title":"Voclosporin: A comprehensive review of its role as a novel calcineurin inhibitor in the management of systemic lupus erythematosus","volume":"104","author":"Ashinze","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100479","article-title":"Lupus nephritis and beyond: Kidney-intrinsic genetic risk for antibody deposition","volume":"2","author":"Chernova","year":"2021","journal-title":"Cell Rep Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-020-03248-z","article-title":"LncRNA NEAT1 accelerates renal mesangial cell injury via modulating the miR-146b\/TRAF6\/NF-\u03baB axis in lupus nephritis","volume":"382","author":"Zhang","year":"2020","journal-title":"Cell Tissue Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-022-00788-6","article-title":"CircRTN4 aggravates mesangial cell dysfunction by activating the miR-513a-5p\/FN axis in lupus nephritis","volume":"102","author":"Miao","year":"2022","journal-title":"Lab Invest"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.584414","article-title":"Interleukin-22 from type 3 innate lymphoid cells aggravates lupus nephritis by promoting macrophage infiltration in lupus-prone mice","volume":"12","author":"Hu","year":"2021","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110181","article-title":"Functional consequence of iron dyshomeostasis and ferroptosis in systemic lupus erythematosus and lupus nephritis","volume":"262","author":"Morel","year":"2024","journal-title":"Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2024.2329293","article-title":"Discovery of lupus nephritis targeted inhibitors based on De novo molecular design: comprehensive application of vinardo scoring, ADMET analysis, and molecular dynamics simulation","volume":"43","author":"Zhang","year":"2025","journal-title":"J Biomol Struct Dyn"},{"key":"B54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.trsl.2022.03.001","article-title":"CD11b agonists offer a novel approach for treating lupus nephritis","volume":"245","author":"Villanueva","year":"2022","journal-title":"Transl Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08917-7","article-title":"A contemporary update on the diagnosis of systemic lupus erythematosus","volume":"63","author":"Huang","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11149","article-title":"Expanded autoantibody profiles for subsetting of Native American, African American, and European American patients with systemic lupus erythematosus","volume":"2","author":"Guthridge","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06146-7","article-title":"Autoantibody cluster analysis in juvenile lupus nephritis","volume":"41","author":"Sherman","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/eji.202149279","article-title":"MHC haplotype and B cell autoimmunity: Correlation with pathogenic IgG autoantibody subclasses and Fc glycosylation patterns","volume":"52","author":"Nogueira Almeida","year":"2022","journal-title":"Eur J Immunol"},{"key":"B59","article-title":"A boy presenting with a fever and pancytopenia diagnosed with systemic lupus erythematosus without a positive anti-ds-DNA antibody result or hypocomplementemia: A case report","volume":"47","author":"Kama","year":"2022","journal-title":"Tokai J Exp Clin Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.kint.2024.10.018","article-title":"Lupus nephritis: redefining the treatment goals","volume":"107","author":"De Vriese","year":"2025","journal-title":"Kidney Int"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2019.10.034","article-title":"A case report of recurrent lupus nephritis 15 days after renal transplantation","volume":"52","author":"Romero Karam","year":"2020","journal-title":"Transplant Proc"},{"key":"B62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12026-012-8345-z","article-title":"Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus","volume":"55","author":"Giles","year":"2013","journal-title":"Immunol Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3389\/fimmu.2019.01667","article-title":"Anti-double stranded DNA antibodies: Origin, pathogenicity, and targeted therapies","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41419-020-02928-6","article-title":"Autoantibody-dependent amplification of inflammation in SLE","volume":"11","author":"Lou","year":"2020","journal-title":"Cell Death Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-lupus21century.39","article-title":"Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus","volume":"218","author":"Hartl","year":"2021","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00848","article-title":"C1q A08 is a half-cryptic epitope of anti-C1q A08 antibodies in lupus nephritis and important for the activation of complement classical pathway","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/nep.14194","article-title":"Anti-C1q antibodies in lupus nephritis children with glomerular microthrombosis","volume":"28","author":"Zhang","year":"2023","journal-title":"Nephrol (Carlton)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.284008","article-title":"Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity","volume":"31","author":"Emad","year":"2020","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/106904","article-title":"The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy","volume":"2015","author":"Moroni","year":"2015","journal-title":"J Immunol Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.7499\/j.issn.1008-8830.2404159","article-title":"Correlation of anti-C1q antibodies with active systemic lupus erythematosus and lupus nephritis in children","volume":"26","author":"Li","year":"2024","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169281","article-title":"Autoantibodies against complement classical pathway components C1q, C1r, C1s and C1-Inh in patients with lupus nephritis","volume":"23","author":"Radanova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13075-025-03536-5","article-title":"Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis","volume":"27","author":"Calatroni","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.401","article-title":"Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity","volume":"9","author":"Shang","year":"2021","journal-title":"Immun Inflammation Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1410032","article-title":"Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review","volume":"15","author":"Calatroni","year":"2024","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1684\/abc.2025.2014","article-title":"Immunological monitoring in systemic lupus erythematosus: Which markers for which lupus]","volume":"83","author":"Tahiat","year":"2026","journal-title":"Ann Biol Clin (Paris)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.2147\/oarrr.s317315","article-title":"Autoantibody profile of Egyptian juvenile systemic lupus erythematosus patients and its association with clinical characteristics and disease activity","volume":"13","author":"Abd El Monem Teama","year":"2021","journal-title":"Open Access Rheumatol"},{"key":"B77","article-title":"Predictors of adverse pregnancy outcome in a cohort of women with systemic lupus erythematosus in Malaysia","volume":"76","author":"Ong","year":"2021","journal-title":"Med J Malaysia"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/xspect","article-title":"The association between active proliferative lupus nephritis during pregnancy and small for gestational age newborns","volume":"39","author":"Ignacchiti Lacerda","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.75917","article-title":"Association of anti-Smith, anti-Ro, and anti-ribonucleoprotein combination with accelerated development of lupus nephritis in systemic lupus erythematosus patients in Saudi Arabia","volume":"16","author":"Alsalman","year":"2024","journal-title":"Cureus"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.060425.acl","article-title":"The long-term outcomes of pulmonary hypertension in systemic lupus erythematosus (SLE-PAH) vary among different autoantibody-based clusters: An observational, longitudinal study conducted at a single centre in India","volume":"36","author":"Baisya","year":"2025","journal-title":"Mediterr J Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-020-0114-4","article-title":"Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis","volume":"60","author":"Miguel","year":"2020","journal-title":"Adv Rheumatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/lyd5es","article-title":"High sensitivity measurement of circulating interferon proteins in systemic lupus erythematosus","volume":"44","author":"Huang","year":"2026","journal-title":"Clin Exp Rheumatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199905)42:5<833::aid-anr1>3.3.co;2-k","article-title":"The key role of nucleosomes in lupus","volume":"42","author":"Amoura","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14165714","article-title":"Autoantibodies in systemic lupus erythematosus: Diagnostic and pathogenic insights","volume":"14","author":"Pagkopoulou","year":"2025","journal-title":"J Clin Med"},{"key":"B85","doi-asserted-by":"crossref","DOI":"10.2298\/SARH1408431Z","article-title":"Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus","volume":"142","author":"Zivkovi\u0107","year":"2014","journal-title":"Srp Arh Celok Lek"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00942-w","article-title":"Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity","volume":"23","author":"Zeng","year":"2023","journal-title":"Clin Exp Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1177\/09612033241260231","article-title":"The additional role of anti-nucleosome antibodies in the prediction of renal damage in systemic lupus erythematosus based on CSTAR (XXV)","volume":"33","author":"Ding","year":"2024","journal-title":"Lupus"},{"key":"B88","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/09612033231217351","article-title":"The estimated prevalence of antiphospholipid antibodies and criteria-antiphospholipid syndrome in subjects with renal thrombotic microangiopathy","volume":"33","author":"Aluf","year":"2024","journal-title":"Lupus"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omaa117","article-title":"Case of an unusual diagnosis of primary antiphospholipid syndrome with multiple clinical complications","volume":"2020","author":"Tsiakas","year":"2020","journal-title":"Oxf Med Case Rep"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/nep.70111","article-title":"Isolated antiphospholipid syndrome nephropathy (aPL nephropathy)-a rare cause of a rapid decline in kidney function in a patient with systemic lupus erhythematosus","volume":"30","author":"Kurginian","year":"2025","journal-title":"Nephrol (Carlton)"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaf326","article-title":"Renal thrombotic microangiopathy impairs renal function recovery in lupus nephritis","volume":"18","author":"Zhang","year":"2025","journal-title":"Clin Kidney J"},{"key":"B92","doi-asserted-by":"publisher","first-page":"Si4","DOI":"10.1093\/rheumatology\/kead603","article-title":"Antiphospholipid syndrome pathogenesis in 2023: An update of new mechanisms or just a reconsideration of the old ones","volume":"63","author":"Raschi","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15082","article-title":"Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications","volume":"19","author":"Chaturvedi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-024-01148-7","article-title":"Antiphospholipid patients admitted in the intensive care unit: What must the rheumatologist know","volume":"26","author":"Moyon","year":"2024","journal-title":"Curr Rheumatol Rep"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103158","article-title":"Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis","volume":"21","author":"Domingues","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-019-00698-9","article-title":"Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis","volume":"33","author":"Sciascia","year":"2020","journal-title":"J Nephrol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2025-1565","article-title":"Antiphosphatidylserine\/prothrombin antibodies define a high-risk antiphospholipid syndrome profile associated with organ damage","volume":"64","author":"Hoxha","year":"2026","journal-title":"Clin Chem Lab Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-021-00581-2","article-title":"Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis","volume":"10","author":"Horita","year":"2021","journal-title":"CEN Case Rep"},{"key":"B99","article-title":"Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy","volume":"37","author":"Fani","year":"2020","journal-title":"G Ital Nefrol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1460317","article-title":"Case report: Timing of eculizumab treatment in catastrophic antiphospholipid syndrome","volume":"15","author":"Carrara","year":"2024","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1055\/a-0976-8893","article-title":"Update membranous nephropathy","volume":"145","author":"Hoxha","year":"2020","journal-title":"Dtsch Med Wochenschr"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad228","article-title":"Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond","volume":"17","author":"Murtas","year":"2024","journal-title":"Clin Kidney J"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1097\/mnh.0000000000000697","article-title":"Membranous nephropathy: current understanding of various causes in light of new target antigens","volume":"30","author":"Ronco","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B104","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.kint.2022.09.008","article-title":"Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice","volume":"103","author":"Tomas","year":"2023","journal-title":"Kidney Int"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2023.2271986","article-title":"Containing anti-PLA2R IgG antibody induces podocyte injury in idiopathic membranous nephropathy","volume":"45","author":"Zhang","year":"2023","journal-title":"Ren Fail"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2025.2595372","article-title":"Long non-coding RNA NEAT1 mediated lupus nephritis induced podocytes pyroptosis through DNMT1-STING axis","volume":"47","author":"Zeng","year":"2025","journal-title":"Ren Fail"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2021.11.041","article-title":"De novo membranous nephropathy associated with antibody-mediated rejection in kidney transplant recipients","volume":"54","author":"de Sousa","year":"2022","journal-title":"Transplant Proc"},{"key":"B108","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-med-050522-034537","article-title":"Novel antigens and clinical updates in membranous nephropathy","volume":"75","author":"Avasare","year":"2024","journal-title":"Annu Rev Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22134","article-title":"Therapeutic plasmapheresis in idiopathic membranous nephropathy anti-PLA2R-related: A case series","volume":"39","author":"Musone","year":"2024","journal-title":"J Clin Apher"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2023.1110355","article-title":"Treatment of membranous nephropathy: Perspectives on current and future therapies","volume":"3","author":"Shah","year":"2023","journal-title":"Front Nephrol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102977","article-title":"Anti-alpha enolase multi-antibody specificity in human diseases. Clinical significance and molecular mechanisms","volume":"20","author":"Angeletti","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01049-2","article-title":"B1-cell-produced anti-phosphatidylserine antibodies contribute to lupus nephritis development via TLR-mediated Syk activation","volume":"20","author":"Ma","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56090430","article-title":"Complement properdin determines disease activity in MRL\/lpr mice","volume":"56","author":"Alaridhee","year":"2020","journal-title":"Med (Kaunas)"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2020.05.005","article-title":"Anti-complement factor H autoantibodies may be protective in lupus nephritis","volume":"508","author":"Li","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2180708","DOI":"10.21203\/rs.2.23421\/v1","article-title":"Anti-tyro3 igG associates with disease activity and reduces efferocytosis of macrophages in new-onset systemic lupus erythematosus","volume":"2020","author":"Zhou","year":"2020","journal-title":"J Immunol Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.molimm.2025.02.018","article-title":"A retrospective study on the correlation between antibody levels and endothelial function in SLE patients: An analysis based on ultrasound and serum biomarkers","volume":"181","author":"Xia","year":"2025","journal-title":"Mol Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.1.62","article-title":"IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus","volume":"41","author":"Bijl","year":"2002","journal-title":"Rheumatol (Oxford)"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(92)90097-8","article-title":"IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis","volume":"63","author":"Prada","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn453","article-title":"Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis","volume":"24","author":"Fang","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-024-00850-0","article-title":"The role of antibody glycosylation in autoimmune and alloimmune kidney diseases","volume":"20","author":"Beyze","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221074184","article-title":"IgA anti-dsDNA antibodies: A neglected serological parameter in systemic lupus erythematosus","volume":"31","author":"Lee","year":"2022","journal-title":"Lupus"},{"key":"B122","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clinbiochem.2020.12.004","article-title":"Perinuclear anti-neutrophil cytoplasmic antibody in systemic lupus erythematosus indicates more severe condition","volume":"89","author":"Pan","year":"2021","journal-title":"Clin Biochem"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26188769","article-title":"Distinction between proliferative lupus nephritis and membranous lupus nephritis based on inflammation, NETosis, and glomerular exostosin","volume":"26","author":"Wada","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.09.016","article-title":"Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis","volume":"100","author":"Caza","year":"2021","journal-title":"Kidney Int"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1159\/000534037","article-title":"A case of NCAM1-positive lupus nephritis with NCAM1 antibody titers responsive to rituximab","volume":"148","author":"Wang","year":"2024","journal-title":"Nephron"},{"key":"B126","doi-asserted-by":"publisher","first-page":"654652","DOI":"10.21203\/rs.3.rs-126613\/v1","article-title":"The spectrum of C4d deposition in renal biopsies of lupus nephritis patients","volume":"12","author":"Ding","year":"2021","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/fl31td","article-title":"Lupus or not? Idiopathic full house glomerulonephritis: a rare nephropathy with unexpectedly severe outcome","volume":"43","author":"Sciascia","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1749548","article-title":"Analysis of various types of glomerulonephritis with crescents at a single center","volume":"2022","author":"Nakakita","year":"2022","journal-title":"Int J Nephrol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.2478\/aite-2024-0017","article-title":"Angiotensin II type 2 receptor antibodies in glomerular diseases","volume":"72","author":"Szymczak","year":"2024","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1169084","article-title":"Telitacicept for autoimmune nephropathy","volume":"14","author":"Cai","year":"2023","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/pediatric14020030","article-title":"Lupus nephritis, autoantibody production and kidney outcomes in males with childhood-onset systemic lupus erythematosus","volume":"14","author":"Wenderfer","year":"2022","journal-title":"Pediatr Rep"},{"key":"B132","doi-asserted-by":"publisher","first-page":"100640","DOI":"10.1016\/j.medj.2025.100640","article-title":"B cell depletion in lupus nephritis: From disappointments to hopes, despite some concerns","volume":"6","author":"Enfrein","year":"2025","journal-title":"Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777197","article-title":"Anti-TLR7 antibody protects against lupus nephritis in NZBWF1 mice by targeting B cells and patrolling monocytes","volume":"12","author":"Murakami","year":"2021","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/h03g16","article-title":"Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases","volume":"43","author":"Buzzulini","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.04.003","article-title":"New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity-could anti-LIN28A enhance precision in diagnostics","volume":"84","author":"Parodis","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1524940","DOI":"10.2139\/ssrn.4890664","article-title":"Identification of novel autoantibodies in Sj\u00f6gren's disease","volume":"16","author":"Engelke","year":"2025","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25652","article-title":"Serum soluble mediator signatures of lupus nephritis: histologic features and response to treatment","volume":"78","author":"Fava","year":"2026","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000200216","article-title":"Membrane proteome-wide screening of autoantibodies in CIDP using human cell microarray technology","volume":"11","author":"Caballero-\u00c1vila","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07158-1","article-title":"HIPK3 hypomethylation as a potential epigenetic biomarker in rheumatic immune diseases with emphasis on rheumatoid arthritis","volume":"44","author":"Jiang","year":"2025","journal-title":"Clin Rheumatol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-023-03420-8","article-title":"NR_103776.1 as a novel diagnostic biomarker for systemic lupus erythematosus","volume":"193","author":"Wang","year":"2024","journal-title":"Ir J Med Sci"},{"key":"B141","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12920-022-01225-9","article-title":"Expression profile of circRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis","volume":"15","author":"Lu","year":"2022","journal-title":"BMC Med Genomics"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224788","article-title":"Single-cell profiling reveals kidney CD163(+) dendritic cell participation in human lupus nephritis","volume":"83","author":"Chen","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl1666","article-title":"Childhood-onset lupus nephritis is characterized by complex interactions between kidney stroma and infiltrating immune cells","volume":"16","author":"Danaher","year":"2024","journal-title":"Sci Transl Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2941-1","article-title":"Decoding myofibroblast origins in human kidney fibrosis","volume":"589","author":"Kuppe","year":"2021","journal-title":"Nature"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/s41590-019-0529-4","article-title":"Author Correction: Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways","volume":"20","author":"Der","year":"2019","journal-title":"Nat Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.01.052","article-title":"Clinical relevance of anti-C3 and anti-C4 autoantibodies in lupus nephritis","volume":"9","author":"Vasilev","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.19723\/j.issn.1671-167X.2022.06.006","article-title":"Characteristics of serum autoantibodies in patients with lupus nephritis and tubulointerstitial damage","volume":"54","author":"Zhang","year":"2022","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/art.42941","article-title":"Association of autoantibody concentrations and trajectories with lupus nephritis histologic features and treatment response","volume":"76","author":"Fava","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1177\/09612033261430585","article-title":"Clinical, serological, and targeted genetic analysis of systemic lupus erythematosus in Kazakhstan","volume":"35","author":"Zaripova","year":"2026","journal-title":"Lupus"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.2196\/68704","article-title":"Improving phenotyping of patients with immune-mediated inflammatory diseases through automated processing of discharge summaries: Multicenter cohort study","volume":"13","author":"Remaki","year":"2025","journal-title":"JMIR Med Inform"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-025-04441-1","article-title":"Therapeutic progress in the targeting of B cells in lupus nephritis: Pathogenesis to clinical research","volume":"57","author":"Lu","year":"2025","journal-title":"Int Urol Nephrol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/1744666x.2023.2145281","article-title":"B cell depletion and inhibition in systemic lupus erythematosus","volume":"19","author":"Krustev","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119894","article-title":"Precision medicine in lupus nephritis","volume":"562","author":"Sharafaldin","year":"2024","journal-title":"Clin Chim Acta"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2025.2612417","article-title":"The cGAS-STING pathway in systemic lupus erythematosus and lupus nephritis: A review of novel therapeutic targets","volume":"59","author":"Li","year":"2026","journal-title":"Autoimmunity"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2025.100322","article-title":"Novel variants in ARID1B, SPSB1, and RAET1-AS shape genetic susceptibility and protection in systemic lupus erythematosus and lupus nephritis","volume":"11","author":"Chen","year":"2025","journal-title":"J Transl Autoimmun"},{"key":"B157","doi-asserted-by":"publisher","first-page":"35534","DOI":"10.1038\/s41598-025-19569-4","article-title":"Identification of genetic variants associated with lupus nephritis in a Taiwanese cohort through systematic genetic screening","volume":"15","author":"Lee","year":"2025","journal-title":"Sci Rep"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1721954","article-title":"Plasma cell-free DNA genome-wide methylation profiling enables detection and activity assessment in systemic lupus erythematosus","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172569","article-title":"Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis","volume":"9","author":"Fava","year":"2024","journal-title":"JCI Insight"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00256","article-title":"Deep phenotyping of urinary leukocytes by mass cytometry reveals a leukocyte signature for early and non-invasive prediction of response to treatment in active lupus nephritis","volume":"11","author":"Bertolo","year":"2020","journal-title":"Front Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210212102438","article-title":"Novel biomarkers for lupus nephritis in the \"OMICS\" era","volume":"28","author":"Dias","year":"2021","journal-title":"Curr Med Chem"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1870304\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:57:44Z","timestamp":1783490264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1870304\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":161,"alternative-id":["10.3389\/fimmu.2026.1870304"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1870304","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"1870304"}}